UBS Group’s Arbor Rapha Capital Bioholdings Corp. I Warrants ARCKW Stock Holding History

UBS Group’s Portfolio ARCKW Stock Details ARCKW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,314	Closed	-$213	–	11473
2022 Q4	$213	Buy	+5,314	New	+$178	﹤0.01%	10310
2022 Q3	–	Sell	-101	Closed	–	–	11490
2022 Q2	$0	Hold	101	–	–	﹤0.01%	11470
2022 Q1	$0	Buy	+101	New	+$37	﹤0.01%	11338

UBS Group's ARCKW Position: Q1 2023 in Review

UBS Group sold out of Arbor Rapha Capital Bioholdings Corp. I Warrants (ARCKW) in Q1 2023, closing a stake of 5,314 shares — an estimated $213 sold.

UBS Group first reported a position in ARCKW in Q1 2022 and held it in 3 quarters. The position peaked at $213 in Q4 2022. 1 fund tracked by Wall St. Rank holds ARCKW as of Q1 2023.

UBS Group reported no remaining Arbor Rapha Capital Bioholdings Corp. I Warrants position as of Q1 2023 after selling out during the quarter.
UBS Group sold 5,314 Arbor Rapha Capital Bioholdings Corp. I Warrants shares in Q1 2023, an estimated $213.
UBS Group first reported a position in Arbor Rapha Capital Bioholdings Corp. I Warrants in Q1 2022 and held it in 3 quarters.
UBS Group's Arbor Rapha Capital Bioholdings Corp. I Warrants position peaked at $213 in Q4 2022.
1 fund tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Warrants as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.